Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathology and molecular updates in tumors of the prostate: towards a personalized approach.
Gasparrini S, Cimadamore A, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Galosi AB, Lopez-Beltran A, Cheng L, Montironi R. Gasparrini S, et al. Among authors: cimadamore a. Expert Rev Mol Diagn. 2017 Aug;17(8):781-789. doi: 10.1080/14737159.2017.1341314. Epub 2017 Jun 15. Expert Rev Mol Diagn. 2017. PMID: 28598696 Review.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.
Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montironi R. Gasparrini S, et al. Among authors: cimadamore a. Asian J Androl. 2017 Aug 4;21(1):19-23. doi: 10.4103/aja.aja_24_17. Online ahead of print. Asian J Androl. 2017. PMID: 28782737 Free PMC article.
Epigenetic Modifications and Modulators in Prostate Cancer.
Cimadamore A, Gasparrini S, Scarpelli M, Doria A, Mazzucchelli R, Massari F, Cheng L, Lopez-Beltran A, Montironi R. Cimadamore A, et al. Crit Rev Oncog. 2017;22(5-6):439-450. doi: 10.1615/CritRevOncog.2017020964. Crit Rev Oncog. 2017. PMID: 29604923 Review.
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
Montironi R, Cimadamore A, Gasparrini S, Mazzucchelli R, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M. Montironi R, et al. Among authors: cimadamore a. Expert Rev Anticancer Ther. 2018 Jul;18(7):685-693. doi: 10.1080/14737140.2018.1469406. Epub 2018 Apr 27. Expert Rev Anticancer Ther. 2018. PMID: 29699428 Review.
Tivozanib for the treatment of renal cell carcinoma.
Santoni M, Massari F, Piva F, Carrozza F, Di Nunno V, Cimadamore A, Martignetti A, Montironi R, Battelli N. Santoni M, et al. Among authors: cimadamore a. Expert Opin Pharmacother. 2018 Jun;19(9):1021-1025. doi: 10.1080/14656566.2018.1480722. Epub 2018 May 31. Expert Opin Pharmacother. 2018. PMID: 29851529
197 results